82 related articles for article (PubMed ID: 3225274)
21. [Implantable catheter systems].
Willnow U
Praxis (Bern 1994); 1998 Sep; 87(36):1135-9. PubMed ID: 9782741
[TBL] [Abstract][Full Text] [Related]
22. Totally implantable central venous access devices in adult oncological patients.
Florio G; Del Papa M; Mari A; Carnì D
Chir Ital; 2008; 60(5):697-702. PubMed ID: 19062492
[TBL] [Abstract][Full Text] [Related]
23. Totally implanted device for long-term intravenous chemotherapy: experience in 123 adult patients with solid neoplasms.
Puig-la Calle J; López Sánchez S; Piedrafita Serra E; Allende Honorato L; Artigas Raventós V; Puig la Calle J
J Surg Oncol; 1996 Aug; 62(4):273-8. PubMed ID: 8691841
[TBL] [Abstract][Full Text] [Related]
24. [Totally implantable central venous systems in neoplastic patients].
Costantini R; Napolitano L; Scurti D; Innocenti P
Ann Ital Chir; 1997; 68(3):357-60. PubMed ID: 9454549
[TBL] [Abstract][Full Text] [Related]
25. Long-term experience with a totally implanted catheter system in gynecologic oncologic patients.
Koonings PP; Given FT
J Am Coll Surg; 1994 Feb; 178(2):164-6. PubMed ID: 8173727
[TBL] [Abstract][Full Text] [Related]
26. Endovascular technique for revision of excess catheter length in subcutaneous implanted venous access devices.
Murthy R; Arbabzadeh M; Richard H; Levitin A; Lund G; Stainken B
Cardiovasc Intervent Radiol; 2004; 27(3):259-61. PubMed ID: 15108022
[TBL] [Abstract][Full Text] [Related]
27. A modified internal jugular vein access for long-term catheter placement in cancer patients.
Pires e Albuquerque M
Ann Surg Oncol; 2007 Feb; 14(2):937-41. PubMed ID: 17103072
[TBL] [Abstract][Full Text] [Related]
28. Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients.
Samaras P; Dold S; Braun J; Kestenholz P; Breitenstein S; Imhof A; Renner C; Stenner-Liewen F; Pestalozzi BC
Oncology; 2008; 74(3-4):237-44. PubMed ID: 18716418
[TBL] [Abstract][Full Text] [Related]
29. The catheter is stuck: complications experienced during removal of a totally implantable venous access device. A single-center study in 200 children.
Wilson GJ; van Noesel MM; Hop WC; van de Ven C
J Pediatr Surg; 2006 Oct; 41(10):1694-8. PubMed ID: 17011271
[TBL] [Abstract][Full Text] [Related]
30. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.
Araújo C; Silva JP; Antunes P; Fernandes JM; Dias C; Pereira H; Dias T; Fougo JL
Eur J Surg Oncol; 2008 Feb; 34(2):222-6. PubMed ID: 17566692
[TBL] [Abstract][Full Text] [Related]
31. Blind percutaneous insertion of Hickman lines by a specialist team.
Hanson JM; Challiss D; Primrose JN; Plusa SM
Ann R Coll Surg Engl; 2001 Sep; 83(5):332-4. PubMed ID: 11806559
[TBL] [Abstract][Full Text] [Related]
32. [A safe and simple method of percutaneous transfemoral implantation of a port-catheter access system for hepatic artery chemotherapy infusion].
Kuroiwa T; Honda H; Yoshimitsu K; Irie H; Aibe H; Shinozaki K; Nishie A; Nakayama T; Masuda K
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1573-7. PubMed ID: 11707983
[TBL] [Abstract][Full Text] [Related]
33. [Cephalic vein access for implantable venous access devices. Technique and long-term follow-up].
Conessa C; Talfer S; Herve S; Chollet O; Poncet JL
Rev Laryngol Otol Rhinol (Bord); 2002; 123(3):143-8. PubMed ID: 12577777
[TBL] [Abstract][Full Text] [Related]
34. Utility and complications of permanent venous access devices (PVAD) in oncological treatments. Follow-up of 100 cases.
Groebli Y; Wutrich P; Safa M; Tschantz P; Callewaert G; Piguet D
Panminerva Med; 1999 Jun; 41(2):89-92. PubMed ID: 10479903
[TBL] [Abstract][Full Text] [Related]
35. [Learning curve and early complications of totally implantable venous access devices: is tutoring the solution for the problem?].
Di Carlo I; Toro A; Sofia M; Fasone MA; Barbagallo F; Russello D
G Chir; 2004 Apr; 25(4):146-8. PubMed ID: 15283408
[TBL] [Abstract][Full Text] [Related]
36. Changing concepts in long-term central venous access: catheter selection and cost savings.
Horattas MC; Trupiano J; Hopkins S; Pasini D; Martino C; Murty A
Am J Infect Control; 2001 Feb; 29(1):32-40. PubMed ID: 11172316
[TBL] [Abstract][Full Text] [Related]
37. A simplified surgical technical procedure for intra-arterial chemotherapy in secondary liver cancer. Experience in 50 patients.
Elias D; Lasser P; Rougier P
Eur J Surg Oncol; 1987 Oct; 13(5):441-8. PubMed ID: 3666161
[TBL] [Abstract][Full Text] [Related]
38. [Central venous access systems in the oncologic patient].
Ragusa M; Alberti D; Argento R; Avenia N; Bartolucci R; Esposito S; Ferilli F; Marini C
Minerva Chir; 2000 Mar; 55(3):139-46. PubMed ID: 10832298
[TBL] [Abstract][Full Text] [Related]
39. Totally implantable central venous access ports for high-dose chemotherapy administration and autologous stem cell transplantation: analysis of overall and septic complications in 68 cases using a single type of device.
Biffi R; Martinelli G; Pozzi S; Cinieri S; Cocorocchio E; Peccatori F; Ferrucci PF; Pistorio R; Andreoni B
Bone Marrow Transplant; 1999 Jul; 24(1):89-93. PubMed ID: 10435741
[TBL] [Abstract][Full Text] [Related]
40. [Pinch-off syndrome and rupture of totally implanted venous access. Report of a case].
Ferrari A; Nahas S; Maccaferri R; Malacarne P
Recenti Prog Med; 2000 Jun; 91(6):297-300. PubMed ID: 11512387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
